Day: December 9, 2020

Regnskabstallene nedenfor er foreløbige og kan blive ændret frem mod offentliggørelse af årsregnskabsmeddelelse og årsrapport den 11. marts 2021.Ved offentliggørelsen af delårsrapporten for 3. kvartal 2020, meddelte selskabet, at der kunne forventes et resultat af primær drift før værdireguleringer i niveauet 23 mio. kr. Denne forventning er uændret.Selskabet har i de seneste måneder konstateret en større efterspørgsel efter den type ejendomme som indgår i selskabets portefølje. Specielt vedrørende lager- og logistikejendommene ses en positiv udvikling i såvel efterspørgsel fra potentielle lejere som i markedsleje, hvilket selskabet opfatter som en konsekvens af den stigende online handel i forbindelse med corona krisen. Ligeledes ses en tendens fra investorer, til i endnu højere grad at efterspørge lager– og logistikejendomme, hvilket...

WALL, N.J., Dec. 09, 2020 (GLOBE NEWSWIRE) — BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of identity and access management (IAM) solutions powered by biometrics will present at the LD Micro Virtual Main Event 2020 Investor Conference on Tuesday, December 15th. BIO-key’s Chairman and CEO Mike DePasquale will give an introduction and address questions from an investor panel, beginning at 3:20pm ET and ending at 3:40pm ET.The LD Micro Virtual Main Event conference takes place December 14th and 15th and will feature over 200 small / micro-cap companies.To learn more or to register for the Main Event please visit: https://ve.mysequire.com/Chris Lahiji, Founder of LD, commented, “This year’s Main Event features a unique format that will make it the first virtual conference this year that is engaging instead of repetitive....

GAITHERSBURG, Md., Dec. 09, 2020 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the appointment of Margaret G. McGlynn, R. Ph. to its board as an independent director. Ms. McGlynn brings extensive pharmaceutical industry, vaccine and non-profit experience to her role on the Novavax Board of Directors.“Margie’s deep experience in vaccine commercialization and understanding of global public health will be invaluable as we move closer to collecting Phase 3 clinical data and submitting NVX-CoV2373, our COVID-19 vaccine candidate, for regulatory authorization and approval,” said Stanley C. Erck, Novavax President and Chief Executive Officer.Ms. McGlynn is currently President and Board Chair for HCU Network America,...

HAMPTON, N.J., Dec. 09, 2020 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced today that the first patient has been dosed in its open label clinical trial in cold contact urticaria and symptomatic dermographism, the two most common forms of chronic inducible urticaria (CIndU). CDX-0159 is a humanized monoclonal antibody developed by Celldex that binds the KIT receptor with high specificity and potently inhibits its activity. The KIT receptor tyrosine kinase is expressed in a variety of cells, including mast cells, which mediate inflammatory responses such as hypersensitivity and allergic reactions. KIT signaling controls the differentiation, tissue recruitment, survival and activity of mast cells. As previously presented, CDX-0159 demonstrated a favorable safety profile as well as profound and durable reductions...

BEVERLY, Mass., Dec. 09, 2020 (GLOBE NEWSWIRE) — LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is pleased to announce that Dr. Jack Regan, LexaGene’s CEO and Founder, will present at the 13th Annual LD Micro Main Event Conference, on December 15, 2020, at 9:00 a.m. (Eastern Time).Interested parties can register to attend at the following link: https://ve.mysequire.com/In addition, the Company is pleased to announce that it has engaged Native Ads, Inc., of New York, New York to perform strategic digital media services, marketing and data analytics services including, but not limited to, content development, video production and editing, website development, media buying and distribution, and campaign reporting and...

VANCOUVER, British Columbia, Dec. 09, 2020 (GLOBE NEWSWIRE) — Marimaca Copper Corp. (“Marimaca Copper” or the “Company”) (TSX: MARI) is pleased to announce the results of a recently completed surface geochemical sampling and reconnaissance mapping program at the Mercedes Target, which is located 3km to the north of the Company’s flagship Marimaca Oxide Deposit (“MOD”).HighlightsGeochemical sampling has identified a large copper anomaly with grades as high as 0.6% in surface samplingCentral geochemical high is approximately 300 metres by 300 metres and is coincident with historical mine workings with grades ranging from 0.2% up to 0.6% copperA large plus 200ppm Cu anomaly extends over an area of approximately 600 metres by 500 metres, which compares favorably to the MODApproximately half of the Mercedes Target is concealed by post...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES.TORONTO, Dec. 09, 2020 (GLOBE NEWSWIRE) — Eloro Resources Ltd. (the “Company” or “Eloro”) (TSX-V: ELO; OTCQX: ELRRF; FSE: P2QM) is pleased to announce that it has entered into an agreement with Haywood Securities Inc. (“Haywood”) to act as lead underwriter and sole bookrunner, on behalf of a syndicate of underwriters including Echelon Wealth Partners Inc. (together with Haywood, the “Underwriters”) pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, 1,936,000 units (the “Units”) at a price of C$1.55 per Unit (the “Issue Price”) for gross proceeds to the Company of C$3,000,800 (the “Offering”).Each Unit will consist of one...

LAS VEGAS, NV, Dec. 09, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — ISW Holdings, Inc. (OTC: ISWH) (“ISW Holdings” or the “Company”), a global brand management holdings company, is pleased to announce that the Company and its largest noteholders have reached an agreement (the “Agreement”) whereby about 50% of the current convertible debt owed by the Company will be exchanged for restricted preferred equity, eliminating a significant portion of the dilution potential from convertible debentures now carried in the Company’s books.Specifically, the Company and its largest noteholder have agreed to exchange convertible debentures (principal and interest) with an aggregate value of $602K for restricted Preferred B equity, thereby reducing total debt and significantly curtailing dilution potential over the coming months and years.“The...

Dr. Arne Materna to join Ares Genetics as new Managing Director and CEO to lead Ares into next phase of its growth Dr. Andreas Posch, while stepping down as Managing Director and CEO to pursue new opportunities, remains on board throughout 2021 as special advisor to facilitate smooth transitionGAITHERSBURG, Md. and VIENNA, Austria, Dec. 09, 2020 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), announced today a planned transition in the leadership of its wholly owned subsidiary Ares Genetics GmbH (Vienna, Austria; “Ares Genetics”). Dr. Andreas Posch, founding CEO of Ares Genetics, has decided to step down as Managing Director and CEO of Ares Genetics at his own request, effective December 31, 2020. As part of the transition planning following the successful business combination with OpGen, Dr. Achim Plum will also step down...

— EXPAREL average daily sales at 103% of the prior year for the month of November 2020 —PARSIPPANY, N.J., Dec. 09, 2020 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the leading provider of innovative non-opioid pain management options, today reported preliminary unaudited net product sales of EXPAREL® (bupivacaine liposome injectable suspension) and iovera° of $38.1 million and $0.8 million, respectively, for the month of November 2020.“We are pleased to report our sixth consecutive month of year-over-year growth for EXPAREL in the face of ongoing challenges from the COVID-19 pandemic. Sales for the final two days of November were meaningfully below the daily average for the month, which we believe to be attributable to the Thanksgiving holiday. Such anomalies aside, market indicators remain favorable...